Skip to content

BIOSYNERGY INC: 10-Q filed 2020-12-15

What BIOSYNERGY INC reported in its quarterly report filed 2020-12-15 (fiscal Q2 2020): 24 published measures, 64 facts as tagged in accession 0001344676-20-000165.

This filing

Form
10-Q (quarterly report)
Filed
2020-12-15
Fiscal period
fiscal Q2 2020
Accession
0001344676-20-000165 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All BIOSYNERGY INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-10-311,939,454USD
At 2020-04-302,007,786USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-10-311,738,124USD
At 2020-04-301,723,201USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-10-311,260,141USD
At 2020-04-301,245,282USD
At 2019-10-311,224,170USD
At 2019-04-301,180,125USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-08-01 to 2020-10-3128,142USD92
2020-05-01 to 2020-10-3114,923USD184
2019-08-01 to 2019-10-3116,990USD92
2019-05-01 to 2019-10-3125,568USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-05-01 to 2020-10-3114,859USD184
2019-05-01 to 2019-10-3144,045USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-10-311,101,998USD
At 2020-04-301,087,075USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2020-08-01 to 2020-10-3111,217USD92
2020-05-01 to 2020-10-315,948USD184
2019-08-01 to 2019-10-316,771USD92
2019-05-01 to 2019-10-3110,191USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-10-315,295USD
At 2020-04-307,527USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-08-01 to 2020-10-3138,764USD92
2020-05-01 to 2020-10-3119,654USD184
2019-08-01 to 2019-10-3123,131USD92
2019-05-01 to 2019-10-3134,499USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-10-311,685,130USD
At 2020-04-301,696,124USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-10-31132,528USD
At 2020-04-30166,793USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-10-314,711USD
At 2020-04-3023,114USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-10-31262,134USD
At 2020-04-30262,939USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-08-01 to 2020-10-31164,809USD92
2020-05-01 to 2020-10-31363,487USD184
2019-08-01 to 2019-10-31180,619USD92
2019-05-01 to 2019-10-31378,859USD184

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-08-01 to 2020-10-31203,573USD92
2020-05-01 to 2020-10-31383,141USD184
2019-08-01 to 2019-10-31203,750USD92
2019-05-01 to 2019-10-31413,358USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-08-01 to 2020-10-3136,787USD92
2020-05-01 to 2020-10-3176,840USD184
2019-08-01 to 2019-10-3139,175USD92
2019-05-01 to 2019-10-3179,097USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-10-3114,935,511shares
At 2020-04-3014,935,511shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-10-31144,855USD
At 2020-04-30193,140USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-10-31226,399USD
At 2020-04-30226,399USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-10-31221,104USD
At 2020-04-30218,872USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2020-10-3119,812USD
At 2020-04-3019,812USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-08-01 to 2020-10-3188,953USD92
2020-05-01 to 2020-10-31202,492USD184
2019-08-01 to 2019-10-3197,678USD92
2019-05-01 to 2019-10-31208,194USD184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2020-05-01 to 2020-10-316,822USD184
2019-05-01 to 2019-10-316,822USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-05-01 to 2020-10-31-11,168USD184
2019-05-01 to 2019-10-31-5,719USD184

Inspect the source

Entity
BIOSYNERGY INC / CIK 0000715812
Captured
SEC response SHA-256
eb912604535d1396c8e2ed6025c6adab35af75fdfc7239083d444e5a31df6a03

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000715812.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))